A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation

Author： Verhagen Maaike   Kleinjan Marloes   Engels Rutger CME  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.13, Iss.8, 2012-06, pp. : 917-933

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Association of OPRM1 A118G variant with the relative reinforcing value of nicotine

By Ray R.   Jepson C.   Patterson F.   Strasser A.   Rukstalis M.   Perkins K.   Lynch K.   O’Malley S.   Berrettini W.   Lerman C.  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 355-363

Springer Publishing Company

Access to resources Recommend Favorite

Recent developments for smoking cessation and treatment of nicotine dependence

By Balbani Aracy PS   Montovani Jair C  

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 3, 2007-03 ,pp. : 287-297

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomics of Nicotine Dependence and Impact on Smoking Cessation

By  

Current Pharmacogenomics, Vol. 5, Iss. 3, 2007-09 ,pp. : 178-189

Bentham Science Publishers

Access to resources Recommend Favorite

A nicotine vaccine for smoking cessation

By  

Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain

By Walter Carmen   Doehring Alexandra   Oertel Bruno G   Lötsch Jörn  

Pharmacogenomics, Vol. 14, Iss. 15, 2013-11 ,pp. : 1915-1925

Future Medicine

Access to resources Recommend Favorite